drugset / Trial / NCT03745144
Effects of Cladribine Tablets on the PK of Microgynon®
RandomizedCrossoverDouble-blindOther
Summary
The purpose of this study was to investigate the potential effects of cladribine on the pharmacokinetics (PK) of monophasic oral contraceptive microgynon® by assessment of its constituents, ethinyl estradiol (EE) and levonorgestrel (LNG).
Timeline
- Start
- 2019-01-17
- Primary completion
- 2022-09-02
- Completion
- 2022-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cladribine | Small molecule | 10 mg | — |
| Subject | Cladribine | Small molecule | 20 mg | — |
| Subject | Microgynon | Unknown | — | Oral |